Skip to content
HowShorted

Iovance Biotherapeutics, Inc. short interest in 2019

In 2019, Iovance Biotherapeutics, Inc.'s disclosed short interest ran from 11.29% of shares outstanding on 15 Oct 2019 to 11.75% on 31 Dec 2019, a change of +0.46 percentage points. The year's high was 12.98% on 13 Dec 2019 and its low 11.29% on 15 Oct 2019, averaging 12.09% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.69 days on 31 Oct 2019. Full history: Iovance Biotherapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Iovance Biotherapeutics, Inc. in 2019

2019 in figures

Start of year
11.29% (15 Oct 2019)
End of year
11.75% (31 Dec 2019)
Change
+0.46 pp
High
12.98% (13 Dec 2019)
Low
11.29% (15 Oct 2019)
Average
12.09%
Highest days to cover
15.69 (31 Oct 2019)
SEC filings marked
9

Every report in 2019

Iovance Biotherapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Oct 201911.29%13.04results (8-K), results (8-K), 10-K filed, 10-Q filed, results (8-K), 10-Q filed, results (8-K)
31 Oct 201911.72%15.69
15 Nov 201912.44%11.0610-Q filed, results (8-K)
29 Nov 201912.37%13.20
13 Dec 201912.98%13.23
31 Dec 201911.75%12.04

See also: Iovance Biotherapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.